CP3 Associate Director Dr. Inma Hernandez joins Dr. Stacie Dusetzina and Dr. Peter Bach in predicting what might happen under proposed changes in drug rebates, in Politico's Prescription Pulse. Hernandez said that list prices would need to drop in order for insurance plan premiums to stay low but is unlikely to happen.